Home | Contact us | Downloads Search :
Word from Executive GM
About Us
Our Products
Mission & Core Values
Vision
 
About Us  
Who Are We?    

Jazeera Pharmaceutical Industries ( JPI) is a Saudi pharmaceutical manufacturer. Established in the year 1999, JPI's main objective was to manufacture and market high quality healthcare products at a reasonable cost satisfying patient needs in Saudi Arabia and other neighboring markets. Another collateral objective was to be an active participant in reaching regional self-sufficiency in healthcare products and be an essential contributor in enhancing the nation's economic development.

JPI Locations:

  • Main Scientific Office: New Akareya Building, Salah El Din St., P.O. Box 106229, Riyadh 11666, Saudi Arabia
  • Plant:  South of Riyadh, 3 rd Industrial Zone.

Main Therapeutic Areas:

Anti-infe ctives

Musculo-skeletal

Cardiovascular

Alimentary

Respiratory

Dermatology

Genito-urinary

Key Products:

JPI has more than 110 registered products in Saudi Arabia and around the world. These products are actively present in the leading therapeutic areas.

List of Main Products:

Product

Active Ingredient

Omnicef ®

Cefdinir

Megamox ®

Amoxi-Clav

Penetrex ®

Enoxacin

Xefo ®

Lornoxicam

Omeral ®

Omeprazole

Duspamen ®

Mebeverine

Repaderm ®

Aescin +Diethylamine

Diclomax ®

Diclofenac Na

Cefaxon ®

Ceftriaxone

Cefofix ®

Cefuroxime Na

S S Cream ®

Herbal

Paraxone ®

Chlorzoxazone + Paracetamol

Rectacure ®

Tribenoside + Lidocaine

Calcichew D3 ®

Calcium + Vit.D3

Zinopril ®

Lisinopril

Oflam ®

Diclofenac K

Last Update: April 2006